Dr. Shrilakshmi Desiraju
Triphase Pharmaceuticals Pvt.Ltd., India
Title: Enhancing value with Thermostable Probiotics
Biography
Biography: Dr. Shrilakshmi Desiraju
Abstract
Probiotics are vital bacteria that colonize the intestine and modify its microflora with benefits for the host. Development of foods with adequate doses of probiotics is a challenge even now as , several factors during processing and storage affect the viability of probiotics. The food and beverage market is still beset by issues of strain stability, low product shelf life, and challenges in the development of probiotic application technology. Major emphasis has been given to protect the microorganisms with the help of encapsulation technique, by addition of different protectants, and by alteration of processing and storage conditions , which in turn increases the cost of the product. Triphase’s Thermostable natural gut Probiotic strains have the inherent ability to withstand harsh manufacturing process upto 200OC ++ (depending upon strain), especially in Food, Beverage, Bakery and Pharma industries. The TSP strains so develop open a window of opportunity for the Industry where following USP can be applied:
A) Withstand High temperatures up to 200OC. – thereby Cold chain eliminated,
B) pH stable towards acidic stomach conditions,
C) These are non-encapsulated / No enteric Coated, multiple industry applications apart from Diary. Our probiotics are designed to fortify food and beverages and are being further developed as prescription pharmaceutical products to ameliorate the side effects of drug treatments for infectious disease, oral health, cancer, and diabetes immunity therapeutic area also. The platform technology for making them temperature stable Lactobacillus species is US patented. (US Patent no. # 100,58577B2). Canadian and European patent – pending.